Umbilical cord blood (UCB) is a rich source of hematopoietic stem cells (HSCs), which have the potential to develop into various blood and immune cells. HSCs play a crucial role in rebuilding and regulating the immune system and have emerged as an effective treatment option for many immune system disorders.
When transplanted, cord blood stem cells have the potential to restore healthy immune function when affected due to genetic disorders and any other condition. The transplantation usually needs less stringent donor matching and may carry a lower risk of complications as compared to other stem cell sources.
The stem cells present in cord blood are used in the treatment of several immune-related conditions, such as severe combined immunodeficiency (SCID), Wiskott-Aldrich syndrome, chronic granulomatous disease, and other inherited immune deficiencies.
Additionally, they are being investigated for autoimmune diseases such as lupus erythematosus, multiple sclerosis, rheumatoid arthritis, and type 1 diabetes. Researchers are studying the additional applications of these stem cells in regenerative medicine and immune system modulation.
During a cord blood stem cell transplant, healthy stem cells are infused into the individual’s bloodstream. These cells travel to the bone marrow and produce new blood cells and immune cells. As time passes, they can rebuild a functioning immune system and substitute for defective or damaged immune cells.
In some types of autoimmune diseases, stem cell therapy may help regulate abnormal immune responses and improve immune tolerance.
